Navigation Links
RainDance Technologies to Present Workshop on Sequence Enrichment Using Innovative Microdroplet-Based Solutions at ASHG 2008
Date:11/3/2008

LEXINGTON, Mass., Nov. 3 /PRNewswire/ -- RainDance Technologies will present a workshop on sequence enrichment using innovative microdroplet-based solutions at the American Society of Human Genetics (ASHG) 58th Annual Meeting in Philadelphia on Thursday, November 13th.

Recent advances in DNA sequencing technologies have improved accuracy and dramatically reduced cost. However, even with the improved efficiency of "second generation" systems, sequencing thousands of human genomes across various phenotypes is still economically unrealistic. To exploit the full potential of new sequencing techniques, a robust method for isolating biologically relevant genomic loci on the megabase scale will be required.

Analogous to what the massively parallel sequencing technologies have done to improve the efficiency of DNA sequencing, RainDance Technologies has developed a platform to enable the use of PCR for high-throughput amplification of targeted genomic sequences.

The workshop at ASHG 2008 will explain the application of this new technology.

"The Sequence Enrichment application leverages our RainStorm(TM) technology to manipulate picoliter volume droplets in disposable chips. We will present the use of this novel method for enrichment of genomic loci with minimal selection bias prior to sequencing, demonstrating the utility of this approach for the routine application of targeted sequencing," said Jeff Olson, Manager of Nucleic Acid Applications, RainDance Technologies. Olson will lead the workshop.

To register for the workshop, "Sequence Enrichment Using Droplet-Based Microfluidics," visit: http://www.raindancetechnologies.com/ashgworkshop. The workshop will be held at the American Society of Human Genetics (ASHG) 58th Annual Meeting, Thursday, November 13, 2008, from 1:00 - 2:00 p.m. at the Philadelphia Marriott, 4th floor, Room 411.

To learn more ab
'/>"/>

SOURCE RainDance Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. RainDance Technologies to Present Sequence Enrichment Using Droplet-Based Microfluidics Workshop at ASHG 2008
2. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to JCVI
3. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
4. RainDance Dedicates New Headquarters, Manufacturing Facility
5. RainDance Technologies to Dedicate New Headquarters, Manufacturing Facility in Lexington
6. RainDance and Scripps to Collaborate on Targeted Sequencing for Wellderly Study
7. RainDance Technologies Appoints Olex Vice President, System Development
8. RainDance Appoints Kelly Chief Operating Officer
9. RainDance Announces Company Relocation and Manufacturing Startup
10. RainDance Appoints Becker Chief Commercial Officer
11. RainDance Technologies Appoints McNary President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... research executives, scientists, policy makers, and funders today convened ... at the inaugural Partnering for Cures meeting. ... the Milken Institute, convened Partnering for Cures ... discovery into an accessible therapy. This effort unites ...
(Date:12/2/2009)... , - "Bolstering Biodiversity ... Coinciding with the International Year ... hosting an international conference in Libreville,(Gabon) on the ... will be attended by government and state leaders, ...
(Date:12/2/2009)... today announced data presentations on its novel oral JAK2 ... Annual Meeting and Exposition in New Orleans. ,, Data ... Phase 1 dose-escalation trial of SB1518 detailing its safety, ... from 100 to 600 mg. These doses were administered ...
(Date:12/2/2009)... is going through,extraordinary times; markets are in turmoil and ... out that the pharma industry has been,relatively immune to ... During the midst of the ... inaugurated an R&D center in Shanghai, the largest of,its ...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
... QUEBEC CITY, Nov. 3 /PRNewswire-FirstCall/ - AEterna Zentaris ... biopharmaceutical company focused on,endocrine therapy and oncology, today ... patient recruitment for its Phase 2 trial in ... linked to doxorubicin. The decision to enter the ...
... Halozyme Therapeutics, Inc.,(Nasdaq: HALO ), ... the extracellular matrix, today announced it has ... human hyaluronidase enzyme,(rHuPH20) co-formulations with Humulin(R) R ... lispro) in Type 1 diabetic,patients. This study ...
... Deploys Clustered Storage to Help Redefine the ... Economics of Large-Scale Sequencing, SEATTLE, ... storage, today announced that Complete,Genomics, the world,s first provider of ... of Isilon IQ clustered,storage to unify its vast stores of ...
Other Biology Technology:AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients 2Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients 3Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients 4Complete Genomics Chooses Isilon IQ to Power World's First Complete Human Genome Sequencing Service 2Complete Genomics Chooses Isilon IQ to Power World's First Complete Human Genome Sequencing Service 3
(Date:12/3/2009)... of this message: , , Preliminary Press ... California Academy of Sciences museum, Attention PIOs: Sending ... registration deadline 10 December, News Media registration ... THIS MONDAY, 7 December, Who,s coming, , ...
(Date:12/3/2009)... Rapids, Mich. (Dec. 3, 2009) Van Andel ... hormone abscisic acid (ABA) works at the molecular level to ... cold. Their findings, published in the journal Nature ... around the world and combat global food shortages. The ...
(Date:12/3/2009)... of the upcoming forest deal at Copenhagen in order to ... University of Leeds. , Writing today in Nature ... the carbon credit payments to be agreed at Copenhagen, known ... made to forest dwellers directly, and their property rights assured. ...
Breaking Biology News(10 mins):AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL 28R 29 25 MG and 50 MG 53550 1Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL 28R 29 25 MG and 50 MG 53550 2Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 1Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 2Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 3Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 4Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 5Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 6Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 7Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 8Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 9Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 10Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 11Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 12Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 13Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 14Innophos Holdings Inc Reports Second Quarter 2009 Results 53546 15ProAssurance Reports Second Quarter 2009 Results 53542 1ProAssurance Reports Second Quarter 2009 Results 53542 2ProAssurance Reports Second Quarter 2009 Results 53542 3ProAssurance Reports Second Quarter 2009 Results 53542 4ProAssurance Reports Second Quarter 2009 Results 53542 5ProAssurance Reports Second Quarter 2009 Results 53542 6ProAssurance Reports Second Quarter 2009 Results 53542 7ProAssurance Reports Second Quarter 2009 Results 53542 8ProAssurance Reports Second Quarter 2009 Results 53542 9ProAssurance Reports Second Quarter 2009 Results 53542 10ProAssurance Reports Second Quarter 2009 Results 53542 11ProAssurance Reports Second Quarter 2009 Results 53542 12ProAssurance Reports Second Quarter 2009 Results 53542 13
... by the University of Colorado at Boulder reveals that ... source of fine, organic particle pollutants that contribute to ... Angeles region. , According to the study, a much ... is directly emitted by vehicles and industrial processes. Instead, ...
... 24, 2008) Self-guided treatment for depression could ... , Scientists with the National Space Biomedical Research ... that will assist astronauts in recognizing and effectively ... pose a substantial threat to crew safety and ...
... release is available in German . , ... and molluscs more than plants. This is the finding of ... Research (UFZ), TU Berlin, the German Federal Institute of Hydrology ... of observations before and after the Elbe floods of August ...
Other Biology News:CU-Boulder study suggests air quality regulations miss key pollutants 2Coming soon: Self-guided, computer-based depression treatment 2Coming soon: Self-guided, computer-based depression treatment 3Vegetation hardly affected by extreme flood events 2
... The FilterMate is a compact, versatile system ... a 96- or 24-well microplates into a ... microplate liquid scintillation and gamma counter. The ... samples for applications such as cell proliferation, ...
... single use spatulas have been designed to ... are for those interested in eliminating the ... Each spatula is individually packaged, RNase/DNase free, ... is a new product number, created to ...
... Progesterone Receptor (PR) Competitor Assay Kits ... novel progesterone receptor binding compounds using ... utilizes a fusion of glutathione transferase ... human progesterone receptor [PR-LBD(GST)] and a ...
... combine the proven features of the pET, ... provides all of the benefits and versatility ... backbone. The pTriEx vectors have been extensively ... in all three expression systems. In each ...
Biology Products: